discovered CSF3R mutations in most patients with CNL, and in 2016, the World Health Organization (WHO) updated the diagnostic criteria for CNL, ushering in the era of prospective molecular biology diagnosis for this disease (2, 3). Here, CSF3R is linked to chronic neutrophilic leukemia.